Skip to main content Skip to footer
American Family Children's Hospital

Print Friendly Page

Protocol No. NRGGI004

Phase III

Age Group Adult

Scope National

Sponsor Type National

Title NRG-GI004: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or Without Atezolizumab or Atezolizuma

Applicable Disease Sites Colon and Rectum

Drugs Involved 5-fu (5-fluorouracil); Atezolizumab; Avastin (bevacizumab); Eloxatin (oxaliplatin); Eloxatina (oxaliplatin); L-OHP (oxaliplatin); MPDL3280A (Atezolizumab); SR 96669 (oxaliplatin); bevacizumab; leucovorin; leukovorin (leucovorin); lv (leucovorin); oxaliplatin; rhu Mab VEGF (bevacizumab); wellcovorin (leucovorin)

Status Open (affiliates only)

Participating Institutions Aspirus Wausau Hospital, Aspirus Regional Cancer Center; Langlade Memorial Hospital, Aspirus Regional Cancer Ctr; Mercy Health Systems, Janesville